Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,540.00
Bid: 3,525.00
Ask: 3,540.00
Change: 35.00 (1.00%)
Spread: 15.00 (0.426%)
Open: 3,445.00
High: 3,575.00
Low: 3,445.00
Prev. Close: 3,505.00
CLDN Live PriceLast checked at -
Caledonia is an Investment Trust

To grow net assets and dividends over the long term, whilst managing risk to avoid permanent loss of capital.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

13 Jul 2018 07:49

RNS Number : 5685U
Caledonia Investments PLC
13 July 2018
 

 

 

 

CALEDONIA INVESTMENTS ACQUIRES COOKE OPTICS

 

Caledonia Investments plc ("Caledonia") is pleased to announce that it has acquired a majority stake in Cooke Optics Group Ltd ("Cooke"), the UK manufacturer of premium-end cinematography lenses for the film, television and advertising industries, in a transaction which values the business at £96.5m.

 

Founded as a lens manufacturer in 1886, Cooke has been at the centre of the film making business for over a century. Headquartered in Leicester, it is led by Les Zellan (Chairman), Robert Howard (Chief Executive Officer) and Alan Merrills (Chief Operating Officer) and has some 130 full time employees.

 

Caledonia has subscribed £62.5m of equity and £30.0m of debt to acquire approximately 89% of Cooke from its current owners, Growth Capital Partners and Cooke's management team. The management team have reinvested £7.8m of their sales proceeds for the remaining equity.

 

In its most recent audited consolidated accounts, being for its financial year to 30 June 2017, Cooke reported EBITDA of £7.7m and profit before tax of £2.8m, and at that date had gross assets of £33.8m.

 

Commenting on the acquisition, Duncan Johnson, Caledonia's Head of Unquoted Investments, said:

 

"We are delighted to have become owners of such an iconic business and brand as Cooke Optics. Its profitability and high cash generation, combined with its strong competitive position in the film making industry globally, makes it ideally suited to Caledonia's unquoted portfolio. We look forward to working with Les Zellan and his team to take advantage of growth opportunities deriving from Cooke's innovation in full-frame camera lens technology, increased demand from China and the expansion of the digital streaming market globally."

 

Les Zellan, Cooke's Chairman, commented:

 

"We are delighted to be partnering with Caledonia in the next phase of Cooke's development. Caledonia's reputation as a long term, supportive investor gives us confidence that we can continue building the Cooke legacy derived from over 130 years of supporting the film industry."

 

13 July 2018

 

For further information contact:

 

 

Caledonia Investments plc

+44 20 7802 8080

Will Wyatt,

Chief Executive

 

Stephen King,

Finance Director

 

Duncan Johnson,

Head of Unquoted Investments

Media contact:

Tulchan Communications

+44 20 7353 4200

Peter Hewer

Lisa Jarrett-Kerr

This announcement contains inside information in relation to Caledonia.

 

END

 

Notes for editors:

 

Caledonia Investments plc

Caledonia is a self-managed investment trust company listed on the London Stock Exchange with net assets of approximately £1.9bn as at 30 June 2018. The company maintains a concentrated portfolio of international quoted, unquoted and fund investments and has paid an increasing annual dividend for 51 years.

 

In the unquoted arena, Caledonia seeks to invest £25m to £100m in private companies, either on a majority or minority basis, providing a meaningful presence and growth capital supporting double-digit operating margins. Its current unquoted portfolio includes Cobehold (a European unquoted investment house), Seven Investment Management (a provider of discretionary fund management, asset management and self-invest platform services), Buzz Bingo (the UK market leading retail bingo operator), Choice Care Group (a UK learning disability care homes provider) and Liberation Group (the Channel Islands' market leading pub, restaurant and drinks business).

 

For additional information on Caledonia, please visit www.caledonia.com.

 

Cooke Optics

Founded in 1886 and based in Leicester, Cooke manufacturers a wide range of lenses suitable for multiple film applications. For over a century, cinematographers have chosen Cooke lenses for the "Cooke Look", a sharp, subtle, smooth rendering that provides dimensionality and high contrast and pleases the eye.

 

For additional information on Cooke, please visit www.cookeoptics.com.

 

Transaction

Caledonia's investment in Cooke was led by Chris Hodges, Alex Mills and Theo Tizard.

 

Travers Smith (Ian Shawyer, Adam Orr) and Alvarez & Marsal (Adrian Balcombe) respectively provided legal and financial due diligence advice to Caledonia. CiL Management Consultants (Tabitha Elwes) provided commercial due diligence advice and Deloitte (Tim Haden) provided tax advice. Wyvern Partners (Mike Barnes) provided debt advice.

 

PwC (Cara Haffey) and Squire Patton Boggs (Paul Mann) respectively provided corporate finance and legal advice to the vendors.

 

 

 

Neither the contents of Caledonia's nor Cooke's websites, nor the contents of any website accessible from hyperlinks on these websites (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQGGUACMUPRUQW
Date   Source Headline
23rd Nov 20217:00 amRNSBoard Changes
23rd Nov 20217:00 amRNSHalf-year Report
17th Nov 20217:00 amRNSDisposal
4th Nov 202111:22 amRNSNet Asset Value(s)
1st Nov 20219:35 amRNSTotal Voting Rights
29th Oct 20214:49 pmRNSTransaction in Own Shares
15th Oct 20214:57 pmRNSTransaction in Own Shares
8th Oct 20215:16 pmRNSTransaction in Own Shares
7th Oct 202110:48 amRNSNet Asset Value(s)
30th Sep 20215:02 pmRNSTotal Voting Rights
30th Sep 20214:59 pmRNSTransaction in Own Shares
30th Sep 20211:52 pmRNSTransaction in Own Shares
24th Sep 20214:57 pmRNSTransaction in Own Shares
17th Sep 20215:05 pmRNSTransaction in Own Shares
10th Sep 20215:05 pmRNSTransaction in Own Shares
3rd Sep 20215:04 pmRNSTransaction in Own Shares
3rd Sep 202112:12 pmRNSDirector/PDMR Shareholding
31st Aug 20216:00 pmRNSTotal Voting Rights
27th Aug 20215:10 pmRNSTransaction in Own Shares
20th Aug 20214:56 pmRNSTransaction in Own Shares
20th Aug 202110:41 amRNSHolding(s) in Company
13th Aug 20215:13 pmRNSTransaction in Own Shares
9th Aug 202112:12 pmRNSHolding(s) in Company
6th Aug 20215:10 pmRNSTransaction in Own Shares
5th Aug 20219:19 amRNSNet Asset Value(s)
2nd Aug 20217:00 amRNSTotal Voting Rights
23rd Jul 20215:23 pmRNSTransaction in Own Shares
21st Jul 20215:18 pmRNSGovernance Committee Membership
21st Jul 20215:14 pmRNSResult of AGM
16th Jul 20215:08 pmRNSTransaction in Own Shares
16th Jul 20214:29 pmRNSChange of Auditor
7th Jul 202111:50 amRNSNet Asset Value(s) and Portfolio Update
30th Jun 20215:51 pmRNSTotal Voting Rights
30th Jun 20215:50 pmRNSTransaction in Own Shares
28th Jun 20217:00 amRNSTransaction in Own Shares
17th Jun 20215:09 pmRNSAnnual Financial Report
10th Jun 20219:01 amRNSHolding(s) in Company
7th Jun 20214:46 pmRNSDirector/PDMR Shareholding
7th Jun 20214:37 pmRNSDirector/PDMR Shareholding
4th Jun 202111:58 amRNSNet Asset Value(s)
1st Jun 20217:00 amRNSCaledonia Private Capital sells DSE
27th May 20217:00 amRNSFinal Results
7th May 202111:39 amRNSNet Asset Value(s)
6th May 20218:13 amRNSHolding(s) in Company
9th Apr 20219:01 amRNSUnaudited net asset value and portfolio update
25th Mar 20215:45 pmRNSHolding(s) in Company
17th Mar 202110:03 amRNSDisposal
5th Mar 202112:27 pmRNSNet Asset Value(s)
16th Feb 20219:01 amRNSDirector Declaration
4th Feb 20219:11 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.